Evidence map›Paper›PMID 31324689›Full record

ArticleDisease models & mechanisms2019

Characterization of acute TLR-7 agonist-induced hemorrhagic myocarditis in mice by multiparametric quantitative cardiac magnetic resonance imaging.

Nicoleta Baxan, Angelos Papanikolaou, Isabelle Salles-Crawley, Amrit Lota, Rasheda Chowdhury, Olivier Dubois, Jane Branca, Muneer G Hasham, Nadia Rosenthal, Sanjay K Prasad and 3 more

Open access · goldAbstract read
In one paragraph

Article in Disease models & mechanisms, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.5field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 3 countries.

Nicoleta BaxanBiological Imaging Centre, Department of Medicine, Imperial College London, London W12 0NN, UK.
Angelos PapanikolaouNational Heart and Lung Institute, Imperial College London, London W12 0NN, UK.
Isabelle Salles-CrawleyNational Heart and Lung Institute, Imperial College London, London W12 0NN, UK.
Amrit LotaRoyal Brompton Hospital, Royal Brompton and Harefield NHS Foundation Trust, London SW3 6NP, UK.
Rasheda ChowdhuryNational Heart and Lung Institute, Imperial College London, London W12 0NN, UK.
Olivier DuboisBiological Imaging Centre, Department of Medicine, Imperial College London, London W12 0NN, UK.
Jane BrancaThe Jackson Laboratory, 600 Main Street, Bar Harbor, ME 04609, USA.
Muneer G HashamThe Jackson Laboratory, 600 Main Street, Bar Harbor, ME 04609, USA.
Nadia RosenthalNational Heart and Lung Institute, Imperial College London, London W12 0NN, UK.
Sanjay K PrasadRoyal Brompton Hospital, Royal Brompton and Harefield NHS Foundation Trust, London SW3 6NP, UK.
Lan ZhaoBiological Imaging Centre, Department of Medicine, Imperial College London, London W12 0NN, UK.
Sian E HardingNational Heart and Lung Institute, Imperial College London, London W12 0NN, UK.
Susanne SattlerNational Heart and Lung Institute, Imperial College London, London W12 0NN, UK s.sattler@imperial.ac.uk.ORCID 0000-0001-9932-4109
Imperial College London · GBJackson Laboratory · USLaboratoire d’Imagerie Biomédicale · FRRoyal Brompton & Harefield NHS Foundation Trust · GB

Funding

British Heart Foundation FS/17/21/32712British Heart Foundation PG/14/88/31183British Heart Foundation PG/14/90/31219British Heart Foundation PG/16/93/32345British Heart Foundation PG/17/22/32868British Heart Foundation PG/17/42/33039British Heart Foundation PG/18/2/33446British Heart Foundation RG/18/3/33405British Heart Foundation RM/13/1/30157
6 · The paper itself

Abstract

Hemorrhagic myocarditis is a potentially fatal complication of excessive levels of systemic inflammation. It has been reported in viral infection, but is also possible in systemic autoimmunity. Epicutaneous treatment of mice with the Toll-like receptor 7 (TLR-7) agonist Resiquimod induces auto-antibodies and systemic tissue damage, including in the heart, and is used as an inducible mouse model of systemic lupus erythematosus (SLE). Here, we show that overactivation of the TLR-7 pathway of viral recognition by Resiquimod treatment of CFN mice induces severe thrombocytopenia and internal bleeding, which manifests most prominently as hemorrhagic myocarditis. We optimized a cardiac magnetic resonance (CMR) tissue mapping approach for the

Indexed as

Multiparametric Magnetic Resonance ImagingAnimalsFemaleHemorrhageHumansImidazolesInflammationIronMaleMice, Inbred C57BLMyocarditisThrombocytopeniaToll-Like Receptor 7ImidazolesIronresiquimodToll-Like Receptor 7Cardiac hemorrhageCardiac magnetic resonance imagingCMRMRIMyocarditisResiquimodTLR-7

Identifiers

PMID31324689
PMCPMC6737951
OpenAlexW2964303814

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.